Cargando…
Comparison of efficacy and toxicity between nedaplatin and cisplatin in treating malignant pleural effusion
OBJECTIVE: To evaluate the efficacy and safety of nedaplatin versus cisplatin in treating malignant pleural effusion (MPE) caused by cancers. METHODS: The clinical data of 219 MPE patients treated from January 2013 to December 2016 were retrospectively reviewed. Intrapleural infusion with nedaplatin...
Autores principales: | Zhong, Li-Zhe, Xu, Hong-Yan, Zhao, Zhong-Min, Zhang, Guang-Mei, Lin, Feng-Wu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134960/ https://www.ncbi.nlm.nih.gov/pubmed/30233211 http://dx.doi.org/10.2147/OTT.S168391 |
Ejemplares similares
-
Efficacy and toxicity of three concurrent chemoradiotherapy regimens in treating nasopharyngeal carcinoma: Comparison among cisplatin, nedaplatin, and lobaplatin
por: Liang, Xuexia, et al.
Publicado: (2022) -
Hematological Toxicities of Concurrent Chemoradiotherapies in Head and Neck Cancers: Comparison Among Cisplatin, Nedaplatin, Lobaplatin, and Nimotuzumab
por: Wu, Qiuji, et al.
Publicado: (2021) -
Co-existing pericardial and pleural malignant mesothelioma responding well to nedaplatin and pemetrexed: a case report
por: Wu, Mindan, et al.
Publicado: (2023) -
Nedaplatin: a cisplatin derivative in cancer chemotherapy
por: Shimada, Muneaki, et al.
Publicado: (2013) -
Efficacy and Safety of Talc Pleurodesis for Malignant Pleural Effusion: A Meta-Analysis
por: Xia, Huan, et al.
Publicado: (2014)